MX9704775A - Formulaciones reductoras de irritacion de la piel y su uso. - Google Patents

Formulaciones reductoras de irritacion de la piel y su uso.

Info

Publication number
MX9704775A
MX9704775A MX9704775A MX9704775A MX9704775A MX 9704775 A MX9704775 A MX 9704775A MX 9704775 A MX9704775 A MX 9704775A MX 9704775 A MX9704775 A MX 9704775A MX 9704775 A MX9704775 A MX 9704775A
Authority
MX
Mexico
Prior art keywords
skin irritation
methods
formulations
reducing skin
irritation
Prior art date
Application number
MX9704775A
Other languages
English (en)
Other versions
MXPA97004775A (es
Inventor
Gary Scott Hahn
David Orel Thueson
Original Assignee
Cosmederm Technologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23424700&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9704775(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cosmederm Technologies filed Critical Cosmederm Technologies
Publication of MXPA97004775A publication Critical patent/MXPA97004775A/es
Publication of MX9704775A publication Critical patent/MX9704775A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00—Preparations for removing hair or for aiding hair removal
    • A61Q9/02—Shaving preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Se proveen composiciones y métodos para inhibir irritacion de la piel atribuible a irritantes químicos o condiciones ambientales, mediante la aplicacion de una cantidad anti-irritante de cation de calcio divalente soluble en solucion acuosa. El tiempo de curso de la respuesta a la irritacion para un panel de seres humanos tratados con nitrato de calcio 25 mM en un desafío de irritacion de la piel con ácido láctico como se muestra.
MX9704775A 1994-12-21 1995-12-21 Formulaciones reductoras de irritacion de la piel y su uso. MX9704775A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36210194A 1994-12-21 1994-12-21
US362101 1994-12-21
PCT/US1995/016990 WO1996019228A1 (en) 1994-12-21 1995-12-21 Formulations and methods for reducing skin irritation

Publications (2)

Publication Number Publication Date
MXPA97004775A MXPA97004775A (es) 1998-02-01
MX9704775A true MX9704775A (es) 1998-02-28

Family

ID=23424700

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9704775A MX9704775A (es) 1994-12-21 1995-12-21 Formulaciones reductoras de irritacion de la piel y su uso.

Country Status (9)

Country Link
EP (1) EP0801570B1 (es)
JP (1) JPH10511360A (es)
AT (1) ATE284216T1 (es)
AU (1) AU4690196A (es)
BR (1) BR9510488A (es)
CA (1) CA2208268A1 (es)
DE (1) DE69533842T2 (es)
MX (1) MX9704775A (es)
WO (1) WO1996019228A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6203803B1 (en) 1994-12-14 2001-03-20 Societe L'oreal S.A. Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
FR2719474B1 (fr) 1994-05-05 1996-05-31 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.
EP0737471A3 (fr) * 1995-04-10 2000-12-06 L'oreal Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
ES2132855T3 (es) 1995-09-07 1999-08-16 Oreal Extracto de iridaceas y composiciones que lo contienen.
US6168798B1 (en) * 1997-02-03 2001-01-02 Bristol-Myers Squibb Company Non-irritating composition for treating acne and other skin conditions
FR2762839B1 (fr) * 1997-04-30 2001-05-11 Oreal Nouveaux derives de l'acide salicylique et leur utilisation dans une composition cosmetique et/ou dermatologique
WO1999006145A1 (en) * 1997-07-29 1999-02-11 E.I. Du Pont De Nemours And Company Process for the preparation of a catalytic microcomposite from a silicate and a highly fluorinated ion exchange resin
US5972321A (en) * 1998-06-30 1999-10-26 Akpharma Inc. Acid neutralization of skin
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US5955065A (en) * 1998-08-19 1999-09-21 The Gillette Company Antiperspirant compositions containing calcium salts
FR2791260B1 (fr) * 1999-03-26 2003-06-06 Dior Christian Parfums Compositions cosmetiques ou dermatologiques contenant au moins une substance destinee a augmenter la fonctionnalite et/ou l'expression des recepteurs membranaires cd44 des cellules de la peau
US6447754B1 (en) 2000-01-24 2002-09-10 Akpharma Inc. Oral rinse methods and compositions
US7851477B2 (en) 2003-05-22 2010-12-14 L'oreal Method for the treatment of skin
ITMI20040665A1 (it) * 2004-04-02 2004-07-02 Pharmaproducts Uk Ltd Sale di calcio per il trattamento della psoriasi e di dermatiti
US7704531B2 (en) 2005-02-18 2010-04-27 Colgate-Palmolive Company Enhanced efficacy aluminum or aluminum-zirconium antiperspirant salt compositions containing calcium salt(s) and betaine
FR2918883B1 (fr) 2007-07-17 2010-01-15 Oreal Utilisation d'un extrait bacterien cultive sur une eau thermale pour le traitement des peaux seches
US8658225B2 (en) 2008-12-31 2014-02-25 Znova, Llc Herbal-based nasal solution and method of use thereof
WO2011010075A1 (fr) 2009-07-24 2011-01-27 L'oreal Utilisation d'un derive d'acide jasmonique en tant qu'agent apaisant
FR2968952A1 (fr) 2010-12-17 2012-06-22 Oreal Ester d'acide amine n-acyle a titre d'agent apaisant
EP3046632B1 (en) * 2013-09-18 2018-06-13 Glymur B.V. Oral hygiene compositions
US20160235637A1 (en) * 2013-10-09 2016-08-18 Riemann Trading Aps Antiperspirant composition
US11602542B2 (en) * 2014-07-31 2023-03-14 Amorphical Ltd. Non-aqueous liquid and semi-solid formulations of amorphous calcium carbonate
DE102018206624A1 (de) * 2018-04-27 2019-10-31 Beiersdorf Ag Antitranspirantwirksame Zubereitung umfassend Erdalkalimetallsalze und Carbonsäuren

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1072355A (en) * 1964-06-17 1967-06-14 Michael Collin Antiseptic and anti-pruretic solution containing camphor
US3865546A (en) * 1970-10-22 1975-02-11 Collaborative Res Inc Depilatory composition and method of use
GB1334933A (en) * 1971-02-19 1973-10-24 Ahrens G W Reaction products of caldium ascorbate and preparation containing them
US3984540A (en) * 1972-12-20 1976-10-05 Caw Industries, Inc. Method of therapeutically treating damaged and/or infected tissue in warm blooded animals and compositions therefor
US4083965A (en) * 1975-01-16 1978-04-11 Bluhm Henry P Method of and composition for relieving itch, pain and swelling resulting from insect stings and bites and skin contact with noxious plants
US4248861A (en) * 1979-02-21 1981-02-03 Schutt Steven R Skin treatment methods
US4477439A (en) * 1981-04-13 1984-10-16 Walter J. Monacelli Treatment of irritated and excoriated areas around the stoma of ostomy patients
AU3298184A (en) * 1983-09-13 1986-09-11 Ed Giestlich Sohne A.G. Fur Chemische Industrie Topically administrable pharmaceutical compositions
DE3435113A1 (de) * 1984-05-07 1986-04-03 Gödecke AG, 7800 Freiburg Pharmazeutische topische zubereitungen zur foerderung der wundgranulation und epithelisation
JPS61109725A (ja) * 1984-11-02 1986-05-28 Kamehiko Mogi 軟膏
EP0217975B1 (de) * 1985-10-08 1991-12-04 Psori-Med Ag Salzmischung zur Behandlung der Schuppenflechte (Psoriasis) und anderer Hautkrankheiten
US4735802A (en) * 1986-05-05 1988-04-05 Le Bich N Topical dermatological composition and method of treatment
JP2527174B2 (ja) * 1987-03-02 1996-08-21 三菱化学株式会社 皮膚用製剤
US4917889A (en) * 1988-07-14 1990-04-17 Thomas W. Clarke Topical composition and treatment
US5296476A (en) * 1989-09-08 1994-03-22 Henderson Esther G Skin care compositions
JP2681527B2 (ja) * 1990-02-15 1997-11-26 ジャパンファインケミカル株式会社 細胞活性促進外用剤
JPH045224A (ja) * 1990-04-20 1992-01-09 Kao Corp 皮膚清浄・清拭剤組成物
US5571535A (en) * 1990-11-30 1996-11-05 Flowers; Marianne Treatment of topical infections
JPH0735326B2 (ja) * 1990-12-28 1995-04-19 仁尾興産株式会社 入浴剤
JPH05117158A (ja) * 1991-10-22 1993-05-14 Sasaki Kagaku Yakuhin Kk 皮膚外用剤組成物
JPH05123398A (ja) * 1991-11-06 1993-05-21 Tsunemasa Kamiyama 咽喉保護吸入剤並びに吸入器具
JPH0742211B2 (ja) * 1992-01-31 1995-05-10 忠 鄭 水性皮膚及び頭皮・頭髪化粧料
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
JPH06135840A (ja) * 1992-10-22 1994-05-17 Asahi Optical Co Ltd 口内及び外皮・外傷の洗浄消毒剤
AU5589594A (en) * 1992-10-29 1994-05-24 C-P Technology Limited Partnership Mixtures or complexes containing calcium and sulfate

Also Published As

Publication number Publication date
EP0801570A1 (en) 1997-10-22
ATE284216T1 (de) 2004-12-15
BR9510488A (pt) 1998-01-13
DE69533842D1 (de) 2005-01-13
DE69533842T2 (de) 2006-02-16
JPH10511360A (ja) 1998-11-04
AU4690196A (en) 1996-07-10
WO1996019228A1 (en) 1996-06-27
CA2208268A1 (en) 1996-06-27
EP0801570B1 (en) 2004-12-08
EP0801570A4 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
MX9704775A (es) Formulaciones reductoras de irritacion de la piel y su uso.
PL320935A1 (en) Compositions for and methods of reducing skin irritation
DE69530418D1 (de) Formulierungen und verfahren zur verminderung von hautirritationen
CA2122271A1 (en) Use of Salicylic Acid for Regulating Skin Wrinkles and/or Skin Atrophy
BR9609503A (pt) Composto, uso de um composto, processo de tratamento de condições onde a inibição de pde especìfico para cgmp é de benefìcio terapêutico, em corpo de animal humano ou não humano, composição farmacêutica, e processos para preparar a mesma e um composto
EP0802731A4 (en) PROPHYLACTIC TREATMENT OF ALLERGIC CONTACT DERMATITIS
PH17666A (en) Non-yellowing topical pharmaceutical composition
EP0699439A3 (en) Treatment of diseases caused by sebum with inhibitors of acyl CoA cholesterol acyltransferase
ZA957507B (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
ATE150292T1 (de) Titansalz enthaltende, schweisshemmende mittel und zusammensetzung
DK0631772T3 (da) Retinoidholdig sammensætning
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
WO1999006013A3 (de) Mittel und verfahren zur dauerhaften haarverformung und verfahren zur herstellung von n-alkylmercaptoacetamiden
NZ506681A (en) Disinfecting composition
NZ334593A (en) Use of zinc salts of conjugated linoleic acids to treat skin disorders particularly eczema, psoriasis and dermatitis and their use in the treatment of skin cancer
IL72620A (en) 2-hydroxy-benzoyl peroxide and compositions for treating acne
ZA957506B (en) L-carnite salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
ATE130515T1 (de) Mittel zur topischen verabreichung von spironolakton.
ATE157530T1 (de) Mittel zur dauerhaften haarverformung
CA2132528A1 (en) Agent for use as an anti-irritant
ES2017026A6 (es) Nuevas composiciones cosmeticas a base de cromon-carboxilatos.
IE782515L (en) Treating diarrhoea
JPS5587713A (en) Weakly acidic nursery powder
TH40951A (th) สารผสมปกป้องผิวหนัง
MX9605753A (es) Aplicacion de alfahidroxidos en estrias distensas.